|
Type of Company:
Type:
|
Company
|
Ownership: |
Publicly Traded |
Year Founded: |
2014 |
Sector: |
Biotech/Life Sciences
Biotech/Life Sciences
|
Region: |
Lower Mainland / South Coast
Lower Mainland
|
Tags: |
Aequus Pharmaceuticals, neurology, ophthalmology, transplant, TeOra Health
|
Profile Views: |
1,138 Company Profile Views |
|
|
Aequus Pharmaceuticals (TSX-V: AQS) is a rapidly growing specialty pharmaceutical company focused on developing and commercializing high quality, differentiated products. Aequus' management team has a proven track record of managing clinical development, regulatory approval, product launches, and marketing products either directly or through partnerships.
Aequus' commercial pipeline is focused on highly specialized therapeutic areas, including neurology, ophthalmology and transplant. The development stage pipeline includes several products in neurology and psychiatry with a goal of addressing the need for improved medication adherence through enhanced delivery systems.
Aequus intends to commercialize its internal programs in Canada and to establish strategic partnerships to accelerate and maximize the potential of its product candidates worldwide.
Through the recent acquisition of TeOra Health, we have a commercial platform to build on for the launch of additional products that are either created internally or brought in through an acquisition or license.
|
|
|
Date |
Type |
Amount |
Investors |
Nov 20, 2014 |
Private Placement |
$4.2 Million CAD |
|
Aug 11, 2020 |
Private Placement |
$2.5 Million CAD |
|
Date |
Type |
Amount |
Investors |
Nov 20, 2014 |
Private Placement |
$4.2M CAD |
|
Aug 11, 2020 |
Private Placement |
$2.5M CAD |
|
|
|
|
Dec 15, 2020
|
Aequus Provides Third Quarter 2020 Financial Highlights
|
Dec 9, 2020
|
Aequus Announces Leadership Change, Anne Stevens Stepping Down as Chief Operating Officer
|
Oct 26, 2020
|
Aequus Receives Approval for New ‘Evolve - Intensive Gel’ Lubricating Eye Drops in Canada
|
Oct 20, 2020
|
Aequus Extends Commercial Agreement for Specialty Product Tacrolimus IR in Canada
|
Sep 23, 2020
|
Aequus Announces Expansion of Medicom Partnership and Filing with Health Canada for Additional Evolve Dry Eye Product
|
Sep 9, 2020
|
Aequus Provides General Update and Second Quarter 2020 Financial Highlights
|
Aug 26, 2020
|
Aequus Announces New Chief Commercial Officer
|
Aug 17, 2020
|
Aequus Completes $2.5 million Equity Financing
|
Apr 30, 2020
|
Aequus Announces Positive Update on Dry Eye Product Launch Plans
|
Apr 22, 2020
|
Aequus Announces Positive Update on Dry Eye Product Launch Plans
|
|
1 - 10 of 83 results
|
|
 |
|
|
|
Share This Company Profile |
|
Disclaimer: Company Profiles in the Tech Directory on T-Net are created, edited and maintained primarily by employees within individual companies, and are subject to continual change without notice and possible errors and/or omissions. Information within the pages of this Tech Directory is of a general nature intended only for informational purposes, and such information should not be relied upon. T-Net does not warrant or guarantee the quality, accuracy or completeness of such information and expressly disclaims liability for any loss, inconvenience or damages (including special, indirect or consequential damages) caused as a result of any errors in, or omissions from, such information. If you see an error, please let us know. Copyright T-Net. All rights reserved.
|
|